Bioequivalence Study of Venlafaxine Hydrochloride Sustained-Release Capsules in Chinese Healthy Volunteers
Condition:   Bioequivalence Study Interventions:   Drug: Venlafaxine Hydrochloride Sustained-Release Capsules 75 mg;   Drug: EFEXOR® XR Sponsor:   Beijing Tongren Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2020 Category: Research Source Type: clinical trials